title: Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions.
abstract: It is held that immune complexes (IC) play a vital role in the pathogenesis of some of the reactions in leprosy. The complement system is known to solubilize and render IC innocuous. We have previously shown that patients undergoing lepra reactions had lowered complement-mediated IC solubilization (CMS). We, therefore, undertook a prospective study of untreated multibacillary leprosy patients and monitored their CMS levels sequentially while on therapy. In addition, the concentrations of the complement component C3d, immunoglobulins G, A and M, and circulating immune complexes (CIC) were also estimated. A total of 26 patients were included in the study and were investigated at 3-month intervals for 3 years. Thirteen of the 14 patients who did not develop reactions at all had normal CMS values, although all of them showed elevated CIC. From the inception of treatment, 10 of the 12 patients who developed lepra reactions had low CMS values which remained below normal levels even after evidence of complement activation disappeared and long after the subsidence of reaction. It is suggested that this defective CMS acts as a predisposing cause of lepra reactions.
authors.affiliation: Central JALMA Institute for Leprosy, Taj Ganj, Agra, India.
authors.forename: V D
authors.initials: VD
authors.lastname: Ramanathan
authors.forename: P
authors.initials: P
authors.lastname: Tyagi
authors.forename: U
authors.initials: U
authors.lastname: Ramanathan
authors.forename: K
authors.initials: K
authors.lastname: Katoch
authors.forename: U
authors.initials: U
authors.lastname: Sengupta
authors.forename: G
authors.initials: G
authors.lastname: Ramu
mesh_terms: D000328:Adult; D000936:Antigen-Antibody Complex / Q000097:blood / Q000737:chemistry*; D015933:Complement C3d / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D015439:Leprosy, Borderline / Q000276:immunology*; D015440:Leprosy, Lepromatous / Q000276:immunology*; D011446:Prospective Studies; D012995:Solubility
chemical_list: D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D015933:Complement C3d